Therapeutic Drug Monotoring: CYP2C19 genetic polymorphism and major depression

被引：0
|
作者：
Adamovic, I [1 ]
Michaelis, S. [1 ]
Streit, F. [1 ]
Binder, L. [1 ]
Degner, D. [1 ]
机构：
[1] Univ Gottingen, Gottingen, Germany
来源：
PHARMACOPSYCHIATRY | 2020年 / 53卷 / 02期
关键词：
D O I：
10.1055/s-0039-3403049
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P7.4
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [21] Why are the Therapeutic Drug Monitoring Results of Voriconazole Inconsistent with CYP2C19 Genetic Testing?
    Kong, Lingti
    Xie, Mengyuan
    Jiang, Manxue
    Zhu, Yulin
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (05): : 598 - 599
  • [22] CYP2C19 gene polymorphism in Ningxia
    Zhen Yang
    Yunqian Xie
    Daya Zhang
    Yan Zou
    Ximei Li
    Runxiang Chen
    Xiaodong Zhang
    Shiju Chen
    Feihu Bai
    Pharmacological Reports, 2023, 75 : 705 - 714
  • [23] CYP2C19 gene polymorphism in Ningxia
    Yang, Zhen
    Xie, Yunqian
    Zhang, Daya
    Zou, Yan
    Li, Ximei
    Chen, Runxiang
    Zhang, Xiaodong
    Chen, Shiju
    Bai, Feihu
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 705 - 714
  • [24] CYP2C19*2 polymorphism and clopidogrel resistance
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (04): : 505 - 505
  • [25] CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
    de Brito, Rodrigo Bernini
    Ghedini, Paulo Cesar
    HELIYON, 2020, 6 (05)
  • [26] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
    Yu, KS
    Yim, DS
    Cho, JY
    Park, SS
    Park, JY
    Lee, KH
    Jang, IJ
    Yi, SY
    Bae, KS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 266 - 273
  • [27] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Chang‑Keun Cho
    Ji-Young Byeon
    Pureum Kang
    Hye-Jung Park
    Eunvin Ko
    Chou Yen Mu
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 : 111 - 116
  • [28] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Cho, Chang-Keun
    Byeon, Ji-Young
    Kang, Pureum
    Park, Hye-Jung
    Ko, Eunvin
    Mu, Chou Yen
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (02) : 111 - 116
  • [29] Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain
    Stingl, Julia C.
    Scholl, Catharina
    Bosch, Julia E.
    Viviani, Roberto
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [30] A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer
    Isomura, Yoshihiro
    Yamaji, Yutaka
    Ohta, Miki
    Seto, Motoko
    Asaoka, Yoshinari
    Tanaka, Yasuo
    Sasaki, Takashi
    Nakai, Yousuke
    Sasahira, Naoki
    Isayama, Hiroyuki
    Tada, Minoru
    Yoshida, Haruhiko
    Kawabe, Takao
    Omata, Masao
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (10) : 1045 - 1052
12345